2. Metabolic Enzyme/Protease Vitamin D Related/Nuclear Receptor Autophagy
  3. RAR/RXR Endogenous Metabolite Autophagy
  4. Isotretinoin

Isotretinoin  (Synonyms: 13-cis-Retinoic acid)

Cat. No.: HY-15127 Purity: 99.90%
COA
SDS
Handling Instructions Technical Support

Isotretinoin (13-cis-Retinoic acid) is an orally active vitamin A derivative and is often be used for the research of severe acne. Isotretinoin also shows anticancer activity.

For research use only. We do not sell to patients.

CAS No. : 4759-48-2

Size Price Stock Quantity
100 mg In-stock
500 mg In-stock
1 g In-stock
5 g   Get quote  
10 g   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 13 publication(s) in Google Scholar

Other Forms of Isotretinoin:

Isotretinoin Related Antibodies

Top Publications Citing Use of Products

    Isotretinoin purchased from MedChemExpress. Usage Cited in: Br J Cancer. 2024 Sep;131(4):763-777.  [Abstract]

    Representative zebrafish embryo xenograft images before (Day1) and after 48h (Day3) of treatment and corresponding waterfall plots representing the change from baseline growth of individual NB-S-124 zebrafish embryo neuroblastoma xenografts treated with DMSO (blue), Isotretinoin (500 nM) (red), navitoclax (10 μM) (green), and combination (yellow) for 48 h.

    Isotretinoin purchased from MedChemExpress. Usage Cited in: Cell Oncol (Dordr). 2023 Dec;46(6):1763-1775.  [Abstract]

    Isotretinoin (RA) (1-10 μM; 7 d) treatment reduced cell viability in SK-NBE(2) and SH-SY5Y cells.

    Isotretinoin purchased from MedChemExpress. Usage Cited in: Cell Oncol (Dordr). 2023 Dec;46(6):1763-1775.  [Abstract]

    The morphology changes and quantification of neurite lengths of SK-N-BE(2) cells after TRIM24 KO in the absence or presence of Isotretinoin (RA) (10 μM; 7 d).

    Isotretinoin purchased from MedChemExpress. Usage Cited in: Cell Oncol (Dordr). 2023 Dec;46(6):1763-1775.  [Abstract]

    qRT-PCR analysis of the mRNA levels of neural differentiation marker genes upon Isotretinoin (RA) (10 μM; 7 d) treatment in control and TRIM24-KO SK-N-BE(2) cells. Isotretinoin (RA) upregulated the expression of neural differentiation marker genes.

    Isotretinoin purchased from MedChemExpress. Usage Cited in: Eur J Pharmacol. 2019 May 15:851:174-185.  [Abstract]

    Isotretinoin (2.5-40 μM; 72 h) exhibited strong cytotoxic effects on the proliferation of M14 cells.

    View All RAR/RXR Isoform Specific Products:

    View All Isoforms
    RXRα RXRβ RXRγ

    View All Endogenous Metabolite Isoform Specific Products:

    View All Isoforms
    Human Endogenous Metabolite Microbial Metabolite

    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    Isotretinoin (13-cis-Retinoic acid) is an orally active vitamin A derivative and is often be used for the research of severe acne. Isotretinoin also shows anticancer activity[1][2].

    IC50 & Target[2]

    Human Endogenous Metabolite

     

    Cellular Effect
    Cell Line Type Value Description References
    A549 IC50
    35.8 μM
    Compound: 3, 13-cis-RA
    Cytotoxicity against human A549 cells after 24 hrs by MTT assay
    Cytotoxicity against human A549 cells after 24 hrs by MTT assay
    		[PMID: 19231037]
    F9 ED50
    3.0 x 10-10 M
    Compound: 2a
    Ability to induce differentiation of mouse F9 embryonal carcinoma cells.
    Ability to induce differentiation of mouse F9 embryonal carcinoma cells.
    		[PMID: 2836589]
    HL-60 ED50
    100 nM
    Compound: 2
    Compound was evaluated for the retinoid-induced differentiation of the human myeloid leukemia cell line HL-60 using trans-retinoic acid as the standard.
    Compound was evaluated for the retinoid-induced differentiation of the human myeloid leukemia cell line HL-60 using trans-retinoic acid as the standard.
    		[PMID: 1992144]
    HL-60 ED50
    5.9 x 10-9 M
    Compound: 2
    Concentration required for 50% inhibition of differentiation-inducing activity against human promyelocytic leukemia cell line HL-60
    Concentration required for 50% inhibition of differentiation-inducing activity against human promyelocytic leukemia cell line HL-60
    		[PMID: 1738149]
    In Vitro

    Isotretinoin (13-cis-Retinoic acid) may act as a pro-drug that is converted intracellularly to metabolites that are agonists for RAR and RXR nuclear receptors[1].
    Isotretinoin is highly sensitive to air, heat, and light[3].
    Isotretinoin (0-40 μM; 24-96 h) significantly inhibits HepG2 cell viability[4].
    Isotretinoin (10 μM; 48 h) down-regulates c-MYC mRNA expression and this is partially due to P1 or P2 promoter activity[4].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Isotretinoin Related Antibodies

    Cell Viability Assay[4]

    Cell Line: HepG2
    Concentration: 0.1, 0.5, 1, 5, 10, 20, and 40 μM
    Incubation Time: 24, 48, 72, and 96 h
    Result: Showed a significant reduction in cell viability (less than 30%) at 96 h for all doses.

    RT-PCR[4]

    Cell Line: HepG2
    Concentration: 10 µM
    Incubation Time: 48 h
    Result: Significantly reduced the expression of c-MYC mRNA by ~80%.
    In Vivo

    Isotretinoin (13-cis-Retinoic acid) (1.3-481 μg/L; inhalation exposure; 45 min daily for 2 weeks) is an effective lung cancer chemopreventive agent in A/J Mice[2].
    Isotretinoin accelerates alveolar repair after exodontia in rats[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: Male A/J mice, lung carcinogenesis model[2]
    Dosage: 1.3, 20.7, or 481 μg/L
    Administration: Inhalation exposure, 45 min daily for 2 weeks
    Result: Reduced the tumor multiplicity. Caused up-regulation of lung tissue nuclear retinoic acid receptors (RARs) relative to vehicle-exposed mice, RARα (3.9-fold vehicle), RARβ (3.3-fold), and RARγ (3.7-fold) at 20.7 μg/L.
    Animal Model: Wistar rats, tooth extraction model[3]
    Dosage: 7.5 mg/kg
    Administration: Oral gavage, daily for 30 days
    Result: Accelerated the process of alveolar repair, significantly decreased serum calcium levels.
    Clinical Trial
    Molecular Weight

    300.44

    Formula

    C20H28O2
    CAS No.
    Appearance

    Solid

    Color

    Yellow to orange

    SMILES

    CC1(C)C(/C=C/C(C)=C/C=C/C(C)=C\C(O)=O)=C(C)CCC1
    Structure Classification
    Initial Source
    Shipping

    Room temperature in continental US; may vary elsewhere.
    Storage

    -20°C, protect from light, stored under nitrogen

    *The compound is unstable in solutions, freshly prepared is recommended.

    Solvent & Solubility
    In Vitro: 

    DMSO : 140 mg/mL (465.98 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 3.3285 mL 16.6423 mL 33.2845 mL
    5 mM 0.6657 mL 3.3285 mL 6.6569 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. The compound is unstable in solutions, freshly prepared is recommended.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: ≥ 2.5 mg/mL (8.32 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

      Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
    • Protocol 2

      Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

      Solubility: 2.5 mg/mL (8.32 mM); Suspended solution; Need ultrasonic

      This protocol yields a suspended solution of 2.5 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

      Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    % 
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).

    *The compound is unstable in solutions, freshly prepared is recommended.

    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    Purity & Documentation
    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. The compound is unstable in solutions, freshly prepared is recommended.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 3.3285 mL 16.6423 mL 33.2845 mL 83.2113 mL
    5 mM 0.6657 mL 3.3285 mL 6.6569 mL 16.6423 mL
    10 mM 0.3328 mL 1.6642 mL 3.3285 mL 8.3211 mL
    15 mM 0.2219 mL 1.1095 mL 2.2190 mL 5.5474 mL
    20 mM 0.1664 mL 0.8321 mL 1.6642 mL 4.1606 mL
    25 mM 0.1331 mL 0.6657 mL 1.3314 mL 3.3285 mL
    30 mM 0.1109 mL 0.5547 mL 1.1095 mL 2.7737 mL
    40 mM 0.0832 mL 0.4161 mL 0.8321 mL 2.0803 mL
    50 mM 0.0666 mL 0.3328 mL 0.6657 mL 1.6642 mL
    60 mM 0.0555 mL 0.2774 mL 0.5547 mL 1.3869 mL
    80 mM 0.0416 mL 0.2080 mL 0.4161 mL 1.0401 mL
    100 mM 0.0333 mL 0.1664 mL 0.3328 mL 0.8321 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.

    Isotretinoin Related Classifications

    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Keywords:

    Isotretinoin4759-48-213-cis-Retinoic acidRAR/RXREndogenous MetaboliteAutophagyRetinoic acid receptorsRetinoid X receptorsvitamin Asevere acneanticancerorally activeInhibitorinhibitorinhibit

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

    		  

    Requested Quantity *

    Applicant Name *

    		 

    Salutation

    Email Address *

    		 

    Phone Number *

    Department

    		 

    Organization Name *

    City

    State

    Country or Region *

    		      

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Isotretinoin
    Cat. No.:
    HY-15127
    Quantity:
    MCE Japan Authorized Agent:

    Customer Review

    Thank You for Your Feedback!

    Request for HNMR Report

    Please fill out this form to request the QC report. We will send it to your Email address shortly.

    Your information is safe with us. * Required Fields.

    Product Name

    		  

    Lot #

    Applicant Name *

    		 

    Email Address *

    Phone Number

    		 

    Department *

    Organization Name *

    		 

    Country or Region *

    Remarks

    SAFETY DATA SHEET (SDS)

    English - EN (393 KB) Français - FR (393 KB) Deutsch - DE (393 KB) Norwegian - NO (393 KB) Español - ES (393 KB) Swedish - SV (393 KB) Italian - IT (393 KB) Korean - KR (393 KB) Portuguese - PT (393 KB)

    Request for HNMR Report

    We have received your request and will respond to you as soon as possible.